MPS Powered by Eureka

Forgot your password?

To find the most relevant journal, please insert appropriate keyword to facilitate search.

 

Type keyword

Search Results: cctr

Current Cancer Therapy Reviews

ISSN: 1573-3947 (Print)
eISSN: 1875-6301 (Online)

Current Cancer Therapy Reviews publishes full-length review/mini-reviews, original research articles, drug clinical trial studies and guest-edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal aims to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in the field of cancer therapy. It covers papers related to prevention, diagnosis and treatment of all types of cancers through biomarkers testing, biopsy, chemotherapy, hormone therapy, gene therapy, hyperthermia, immunotherapy, irreversible electroporation, laser therapy, photodynamic therapy, radiation therapy, radiotherapy and stem cell transplantation.

Start Submission

Special Issues With Active Call for Papers

Submission closes on: Nov 02, 2024
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics

The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering. see more

Impact Factor: 0.6
Guest Editor(s): Wenshe sun
Submission closes on: Oct 02, 2024
Current progress in Protein Degradation and Cancer Therapy

argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for the development of cancer therapy. The main focus of TPD is development of heterobifunctional small molecules degraders, including proteolysis-targeting chimeras (PROTACs), which contains two linked... see more

Impact Factor: 0.6
Guest Editor(s): LEA Hassan